A simple and reliable high-performance liquid chromatography method with diode array detection (HPLC-DAD) was developed and validated for the simultaneous determination of six bioactive components, rutaevine, limonin, evodiamine, rutaecarpine, N-formyldihydrorutaecarpine and dihydroevocarpine, in the traditional Chinese medicine Evodiae Fructus (Wuzhuyu in Chinese). HPLC separation was conducted on an Agilent Eclipse C18 column (4.6 3 150 mm, 5 mm) at 358 8 8 8 8C with a mixture of mobile phase A [tetrahydrofuran-0.02% phosphoric acid (16 : 35)] and mobile phase B (acetonitrile) (gradient elution as follows: 0 min, 22% B; 23 min, 22% B; 24 min, 75% B) at a flow rate of 1 mL/min, and the DAD detection wavelength was set at 220 nm. A linear relationship within the range of investigated concentrations was observed for the six compounds, with correlation coefficients greater than 0.999. The average recovery yields of the six compounds ranged from 98.39 to 104.96%. The HPLC-DAD method was validated by its repeatability [relative standard deviation (RSD) < 2.0%] and intra-day and inter-day precision (RSD < 2.0%). The method was successfully applied to the simultaneous determination of the six previously mentioned components in Evodiae Fructus. It is the first report of a simultaneous qualitative and quantitative analysis for three classes of bioactive components in Wuzhuyu, including the indolequinazoline alkaloids, quinolone alkaloid and limonoids. Based on these results, it is suggested, for possible future revision of the Chinese Pharmacopoeia, that the total contents of evodiamine and rutaecarpine are not less than 0.15% and the total contents of rutaevine and limonin are not less than 0.50%.
Introduction
Evodiae Fructus (Wuzhuyu in Chinese) is derived from the dried, unripe fruits of Evodia rutaecarpa (Juss.) Benth, E. rutaecarpa (Juss.) Benth. var. officinalis (Dode) Huang or E. rutaecarpa (Juss.) Benth. var. bodinieri (Dode) Huang. Wuzhuyu has been used as a traditional Chinese medicine for more than 2,000 years. It is officially listed in the Chinese Pharmacopoeia (1) . The chemical components of Wuzhuyu are alkaloids, limonoids, essential oils, carboxylic acids, flavonoids and polycose (2) (3) (4) . Of these, alkaloids and limonoids are considered to be the primary bioactive compounds of Wuzhuyu (5) . Two classes of alkaloids, indolequinazoline alkaloids such as evodiamine, rutaecarpine, N-formyldihydrorutaecarpine and quinolone alkaloid dihydroevocarpine, are presented in Wuzhuyu (Figure 1 ), whereas limonin and rutaevine are the primary limonoids in Wuzhuyu (6) (Figure 1 ). The indolequinazoline alkaloids evodiamine and rutaecarpine in Wuzhuyu display anti-polysarcous (7), cardiotonic (8) , central stimulative (9) , vasodilatory (10), antithrombotic and bronchoconstrictive bioactivities (11) . Quinolone alkaloid dihydroevocarpine displays inhibitory activity against the nuclear factor of activated T-cells (12) . The limonoids limonin and rutaevine have been used to regulate cholesterol levels and to prevent atherosclerosis. The limonoids have also been used as pesticides (13) . Therefore, it is very important to develop an approach to determine the quality and quantity of the three classes of bioactive components of Wuzhuyu, including indolequinazoline alkaloids, quinolone alkaloid and limonoids.
Various analytical methods had been reported for the quantitative determination of Wuzhuyu alkaloids and limonoids (14) (15) (16) (17) (18) . A chromatographic fingerprint of E. rutaecarpa (Juss.) Benth was established by using a high-performance liquid chromatography-diode array detection -electrospray ionization tandem mass spectrometry (HPLC -DAD -ESI-MS n ) method to determine only one of the three species of Wuzhuyu (14) . An HPLC-MS-MS method was developed to quantitatively determine the indoloquinazoline alkaloids of Wuzhuyu (15) . An HPLC-DAD method was developed to quantitatively determine the indoloquinazoline alkaloids and liminoids of only one species (16) . The quantity of dehydroevodiamine in E. rutaecarpa (Juss.) Benth was determined by HPLC (17) . Recently, Wang et al. established an HPLC-DAD -ESI-MS-MS method for the qualitative and quantitative assessment of eight constituents in Evodiae Fructus (18) . However, the quality and quantity of the quinolone alkaloids in Wuzhuyu cannot be determined by the published methods. This paper reports a method for the simultaneous determination of the three primary bioactive components, indolequinazone alkaloids (evodiamine, rutaecarpine and N-formyldihydrorutaecarpine), quinolone alkaloid (dihydroevocarpine) and limonoids (limonin and rutaevine), of the three Wuzhuyu species [E. rutaecarpa (Juss.) Benth, E. rutaecarpa (Juss.) Benth. var. officinalis (Dode) Huang and E. rutaecarpa (Juss.) Benth. var. bodinieri (Dode) Huang] by using HPLC-DAD. The analytical method recommended in the Chinese Pharmacopoeia (1) for the qualitative and quantitative assessment of Wuzhuyu was found to be incorrect because the chromatographic peak for limonin is not only for the compound (19) . Thus, Wuzhuyu materials were collected from different regions at different times to evaluate the contents of the six bioactive components by using the method described here, for possible suggestions for future revision of the Chinese Pharmacopoeia.
Experimental

Chemicals and reagents
Standard substances of evodiamine, rutaecarpine and limonin ( Figure 1) were purchased from the National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). Rutaevine, N-formyldihydrorutaecarpine and dihydroevocarpine ( Figure 1 ) were isolated and identified by extensive spectroscopic data analysis in the authors' laboratory. The purities of rutaevine, N-formyldihydrorutaecarpine and dihydroevocarpine were determined to be 98.4, 99.2 and 98.9%, respectively, by normalization of the peak areas. HPLC-grade acetonitrile and tetrahydrofuran were purchased from Tedia (Fairfield, OH). Water for HPLC was purified in a Milli-Q system (Millipore, Milford, MA). Other reagent solutions were of analytical grade.
Preparation of standard solutions
The reference compounds rutaevine, limonin, evodiamine, rutaecarpine, N-formyldihydrorutaecarpine and dihydroevocarpine were accurately weighed and dissolved in methanol in a 25 mL volumetric flask to produce the stock solutions (0.029, 0.069, 0.012, 0.055, 0.033 and 0.017 mg/mL, respectively). The stock solutions were diluted to appropriate concentrations by adding methanol for the following HPLC analyses. All solutions were stored away from light at 48C.
Plant materials
Authentic fruits of E. rutaecarpa (Juss.) Benth (Samples 1-11, Table I ), E. rutaecarpa (Juss.) Benth. var. officinalis (Dode) Huang (Samples 12-18, Table I ) and E. rutaecarpa (Juss.) Benth. var. bodinieri (Dode) Huang (Samples 19-24, Table I) were collected from various locations throughout China. All were identified by Professor Guangmin Shu at Sichuan Academy of Chinese Medicine Sciences, China.
Preparation of sample solution
To the air-dried and powdered sample (60 mesh, 200 mg) was added 50 mL of 80% aqueous ethanol. The sample was soaked for 1 h at room temperature and then refluxed for 1 h. After cooling to room temperature, an appropriate volume of 80% aqueous ethanol was added to the mixture to equate its weight to the weight of the original mixture. The mixture was filtrated through a 0.45 mm membrane filter to prepare the sample solution for HPLC analyses.
Instrumentation and chromatographic conditions
The HPLC analysis was conducted on an Agilent 1200 instrument equipped with a quaternary pump, a DAD, an autosampler, a column compartment and an Agilent Chemstation HPLC system (Palo Alto, CA). Chromatographic separation was conducted on an Agilent Eclipse C18 column (4.6 Â 150 mm, 5 mm). The mobile phases consisted of tetrahydrofuran-0.02% phosphoric acid solution (13:65) (A) and acetonitrile (B). The gradient program with linear interpolation was as follows: 0 min, 22% B; 23 min, 22% B; 24 min, 75% B. The flow rate was 1.0 mL/min and the detection was set at 220 nm. Ten microliters of the sample solution were injected for analysis.
Method validation
In accordance with the guidelines of the International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use (2005) (20) , the establishing parameters for linearity, limits of detection (LOD) and quantification (LOQ), precision, repeatability, stability, recovery and robustness were used to validate the HPLC method.
Specificity of compounds
The specificity of the compounds was determined by the purity of chromatographic peaks and by comparing the ultraviolet (UV) spectra and retention times of the analytes with those of the authentic standards. If the purity value of a chromatographic peak is equal to or higher than 990, the chromatographic peak is spectrally homogeneous. The UV spectra and purity of the analytes were obtained from DAD.
Linearity
The standard stock solutions were diluted with methanol to offer different working solutions for HPLC analyses. The graphs were plotted after linear regression (Table II) of the peak areas versus the corresponding concentrations to establish the calibration curves of each standard.
LOD and LOQ
LOD and LOQ were determined by signal-to-noise ratios (S/N) of approximately 3 and 10, respectively (Table II) .
Precision
The precision of the method was evaluated with a sample solution under the selected optimal conditions six times in one day for intra-day variation and twice a day on three consecutive days for inter-day variation. The results were expressed as relation standard deviations (RSDs) and are summarized in Table III .
Repeatability
The repeatability was confirmed with six different concentrations prepared from Sample 3. The results are summarized in Table III .
Stability
The stability was tested and analyzed at 0, 1, 2, 4, 8, 12, 24 and 48 h. The results are summarized in Table III .
Recovery
The recovery was performed by adding known amounts of the six standards at medium levels. The spiked samples were extracted, processed and quantified in accordance with the previously described methods. The results are summarized in Table IV .
Robustness
The robustness of the method was tested on Agilent Eclipse C18 and Supelco Discovery C18 columns. The aliquots of the sample solution were separately analyzed by different C18 columns. The contents of the six characteristic compounds were calculated. The mean contents of the six compounds were 0.667, 0.733, 0.114, 1.158, 0.299 and 0.300% for the Agilent Eclipse C18 and 0.669, 0.729, 0.111, 1.150, 0.292 and 0.297% for the Supelco Discovery C18. No significant difference was observed between the two different columns, which indicated that the developed method was capable of being reproduced with acceptable performance.
Result and Discussion
Optimization of chromatographic conditions Different mobile phases (acetonitrile -water, acetonitrile -0.04% phosphoric acid, acetonitrile -methanol -water and acetonitrile -tetrahydrofuran-0.02% phosphoric acid) were used to optimize the chromatographic condition for the six compounds. The results showed that a gradient elution of acetonitrile -tetrahydrofuran -0.02% phosphoric acid efficiently separated the compounds (Figure 2A ). According to the UV spectra of the six compounds recorded by DAD in the range from 200 to 400 nm, the detection wavelength was set at 220 nm because both the total peak areas and the numbers of detectable peaks reached a maximum in the HPLC chromatographic diagram. The typical chromatographic profiles of the standard and sample solutions are shown in Figures 2A and 2B , respectively.
Validation of method HPLC-DAD has the advantage of identifying the analyte by a combination of the retention time and the UV spectrum. In this study, the retention time and the UV spectra (200-400 nm) of the six compounds in samples matched very well with the corresponding standards. The values of the purity of chromatographic peaks were 997.879, 999.598, 999.627, 999.673, 999.787 and 999.834, respectively, for rutaevine, limonin, evodiamine, rutaecarpine, N-formyldihydrorutaecarpine, and dihydroevocarpine in samples. The spectra and purity peaks of analytes are shown in Figure 3 . The results of the calibration curves, LOD and LOQ for the six compounds are summarized in Table II . All calibration curves showed good linear regression (r . 0.999) within the test range. The LOD (S/N ¼ 3) and LOQ (S/N ¼ 10) for the analytes were less than 3.42 and 11.33 ng, respectively. were lower than 2.13%. Thus, the HPLC-DAD method developed in this study was precise, accurate and sensitive enough for the simultaneous quantitative evaluation of rutaevine, limonin, evodiamine, rutaecarpine, N-formyldihydrorutaecarpine and dihydroevocarpine.
Optimization of extraction conditions
The efficiency of extraction with different solvents such as methanol (21) and 80% ethanol (1, 19, 22) , and different extraction methods such as reflux (15 -17, 21) and ultrasonic (14, 18, 19, 22) , were investigated to optimize the extraction conditions. The results revealed that 80% ethanol with refluxing was the optimal extraction combination ( Figure 4 ).
Sample analysis
Initially, the extract of Evodiae Fructus was analyzed by HPLC-DAD using the HPLC conditions recommended in the Chinese Pharmacopoeia (2010 Edition) (1) . On the basis of analysis of the DAD spectrum, it was found that the chromatographic peak of limonin is not pure. Thus, an efficient HPLC separation condition was developed to separate the peak. The results revealed that limonin and N-formyldihydrorutaecarpine could not be separated by using the HPLC condition recommended in the Chinese Pharmacopoeia (19) . Based on previous results, it was decided to determine the six bioactive components of Evodiae Fructus. The chromatographic conditions were further modified to efficiently separate the six compounds (Figure 2A) . The HPLC-DAD method described in this paper was used to identify and quantify the contents of the six bioactive components in Evodiae Fructus ( Figure 2B ). The quantification data are reported in Table V. The content of rutaevine ranged from 0.043 to 0.77%. For the most samples, the contents of rutaevine are more than 0.10%. Only the contents of rutaevine in Samples 1, 6 and 20 are less than 0.10%. The content of limonin ranged from 0.073 to 1.77%. It is defined in the Chinese Pharmacopoeia (1) that the content of limonin in Evodiae Fructus should not be less than 1.0%; otherwise, it would not be used as the raw material and is regarded as a substandard herb. Based on this definition, only Samples 1, 12, 16, 18, 20 and 23 should be certificated to be put into production. However, the contents of limonoids, including rutaevine and limonin, in most samples are higher than 0.50%. The total contents of evodiamine and rutaecarpine ranged from 0.072 to 2.52%. It is defined in the Chinese Pharmacopoeia (1) that the total contents of evodiamine and rutaecarpine in Evodiae Fructus should not be less than 0.15%. Only Samples 1, 6 and 23 should be regarded as substandard herbs. The content of N-formyldihydrorutaecarpine ranged from 0.0038 to 0.35%. The content of dihydroevocarpine ranged from 0.027 to 0.47%.
The contents of rutaevine, limonin, evodiamine, rutaecarpine, N-formyldihydrorutaecarpine and dihydroevocarpine were varied in the samples from different habitats. However, no significant difference in the contents of the six compounds was observed within different species, which is consistent with the Chinese Pharmacopoeia, which states that there is no correlation between the contents of the bioactive compounds and the three species.
Based on the results of these analyses of the contents of the six bioactive compounds of Evodia Fructus, it is suggested that the total contents of evodiamine and rutaecarpine are not less than 0.15% and the total contents of rutaevine and limonin are not less than 0.50% for possible future revision of the Chinese Pharmacopoeia. According to this suggestion, only Samples 1, 6, 8, 11, 17 and 23 are not qualified, which means that the suggestion is reasonable and appropriate. Additionally, a negative correlation trend was observed between the total amounts of evodiamine and rutaecarpine and the content of limonin.
Conclusions
The six bioactive components of Wuzhuyu, rutaevine, limonin, evodiamine, rutaecarpine, N-formyldihydrorutaecarpine and dihydroevocarpine, were separated efficiently by the HPLC -DAD method developed in this study. It is the first report of simultaneously qualitative and quantitative analysis for three classes of bioactive components in Wuzhuyu, including the indolequinazoline alkaloids, quinolone alkaloid and limonoids. Based on these results, it is suggested for possible future revision of the Chinese Pharmacopoeia that the total contents of evodiamine and rutaecarpine are not less than 0.15% and the total contents of rutaevine and limonin are not less than 0.50%. 
